tykhr
sign in
free sign up
Amylyx Pharmaceuticals Inc
Biotechnology
Healthcare
AMLX
89.14 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
13.38
52 week high
13.48
high
13.56
52 week low
0.00
low
13.16
growth
334.84 %
previous Close
13.31
P/E ratio
market cap
887 M
div yield
0
usd
Jun 2025
qoq
revenue
0.00 %
net incoming
-41.44 M
-15.42 %
eps
0.00 %
-9.52 %
eps surprise
0.00 %
net profit margin
-4144300000.00 %
0.00 %
operating incoming
-42.86 M
-13.37 %
net change in cash
-1.68 M
90.48 %
cash on hand
58.09 M
-2.81 %
cost of revenue
141 K
0.00 %
top